Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2025-12-24 @ 1:28 PM
NCT ID:
NCT02848495
Eligibility Criteria:
Inclusion criteria :
* Inclusion criteria indexes and related cases (familial) of intracranial aneurysms:
* Index: Any patient consulting for a major IA and some typical bifurcation with at least one other case reached akin IA 1st degree
* Related: All similar to the first degree, aged 20 or more, patients with a family background of IA and some typical bifurcation (≥2 achieved) For the latter, directed by screening with Magnetic resonance imaging (MRI) sequence Time of Flight (TOF), axial T2, EGT2.
* Consent oral and in writing to the Biocollection consent Form for participation in the collection of biological samples
* Inclusion criteria sporadic cases of IA:
* Any patient consulting for IA and some typical bifurcation
* Patients aged of 20 years or older
* Consent oral and in writing to the Biocollection consent Form for participation in the collection of biological samples
Exclusion Criteria :
\- Non Inclusion Criteria:
* Patients who have shown the inability or have refused to sign the consent informed biocollection
* Syndromic diagnosis known as IA provider
* Marfan Syndrome
* AOS with SMAD 3
* Danlos Syndrome Elhers type II and IV
* Autosomal Dominant Polycystic
* Moyamoya Syndrome
* Character of IA:
* Dissecting or fusiform
* Combined with an arteriovenous malformation
* Blister-like
* Mycotic
* Pathology of the cerebral white matter detected on MRI, evoking:
* COL4A1 mutation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02848495
Study Brief:
Protocol Section:
NCT02848495